Oobli has built a sweet protein platform that produces fermentation-derived proteins (sweet proteins) intended to replace sugar in food and beverage applications. Its core products include proteins such as monellin and brazzein that the company says have no glycemic impact and are climate friendly. Oobli has secured regulatory progress, receiving FDA GRAS "no questions" letters for two sweet proteins and reporting four proteins with self-affirmed FDA GRAS status plus one protein with FDA FEMA GRAS status. The company sells protein-sweetened chocolates and partners with food companies to integrate its proteins both as standalone sweeteners and in combination with other natural sweeteners. Oobli is expanding across food and beverage categories and is collaborating with ingredient partners to scale commercialization. The company is based in Davis, Calif. Joywell Foods is a Devis, CA-based food technology and consumer goods company led by CEO Ali Wing. It uses a proprietary microbial fermentation process to produce nature-identical sweet proteins found in exotic fruits and berries. Over the past 12 months the company has scaled its sweet protein platform across multiple proteins. Joywell is developing consumer products and gearing up for commercial launch. The company intends to use the funds to accelerate R&D and scale up commercialization across its entire sweet protein platform. Joywell raised $25M in the financing. Joywell Foods (previously Miraculex) develops a portfolio of naturally sweet proteins, beginning with miraculin sourced from the miracle berry fruit. Its proprietary technology platform produces proteins using both plants and fermentation. The company is led by CEO Karen Huh and is building a new category of foods based on these naturally sweet proteins. Joywell intends to use new financing to develop its technology platform and processes for commercial scale, broaden its sweet protein portfolio, and expand R&D operations. The article reports the company has raised a total of $13.2M to date.

Total raised

$50M

Funding rounds

3

Latest round

Series B

Latest activity

Feb 2025